natamycin

(redirected from E235)

natamycin

 [nat″ah-mi´sin]
a polyene antibiotic used in topical treatment of fungal keratitis, blepharitis, and conjunctivitis.

pi·mar·i·cin

(pi-mar'i-sin),
An antifungal antibiotic for topical use, produced by Streptomyces natalensis; effective against Aspergillus, Candida, and Mucor species.
Synonym(s): natamycin

natamycin

/nat·a·my·cin/ (nat″ah-mi´sin) a polyene antibiotic used in topical treatment of fungal keratitis, blepharitis, and conjunctivitis.

natamycin

[nat′ämi′sin]
a polyene antibiotic used in topical treatment of fungal keratitis, blepharitis, and conjunctivitis.

antifungal agent 

Any substance which destroys or prevents the growth of fungi. It is one of the antibiotic groups. There are several classes of antifungal drugs: Polyenes, which cause an increase in fungal cell wall permeability leading to its death. Examples: amphotericin B, natamycin, nystatin. Azoles, which act either by inhibiting the synthesis of ergosterol, a component of fungal cell wall or by causing direct wall damage. Examples: clotrimazole, econazole, fluconazole, itraconazole, ketoconazole, miconazole. Pyrimidines, which interfere with the normal function of fungal cells. Example: flucytosine. Syn antimycotic agent.

natamycin

a polyene antibiotic used in topical treatment of fungal infections of the skin, eye and nasal cavity.
References in periodicals archive ?
You may also register in person at Bunker Hill Community College in Charlestown, Room B202 and Room E235.
The quantity of Natamycin found in Zita Dairies Industry products was significantly lower than that detected in previous tests (2,507mg/kg of Natamycin E235 was detected on August 5).
THE first session of the two-day Goffs France Autumn Mixed sale was topped by the Grade 2-placed hurdler King Foraday, bought by P egasus Farms for E235,000.
The Conrad, at E235 and Jurys at E295 a night may have a high enough standard but their ethos is still the same - get them in and get them out.
Earnings before interest, taxes, depreciation and amortization ("EBITDA") improved by 18% to E235 million (2000: E200 million).